tiprankstipranks
Trending News
More News >
Chesnara PLC (GB:CSN)
LSE:CSN
Advertisement

Chesnara (CSN) AI Stock Analysis

Compare
68 Followers

Top Page

GB:CSN

Chesnara

(LSE:CSN)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
287.00p
▲(2.50% Upside)
Chesnara's overall stock score is driven by its strong financial recovery and high dividend yield, which provide a solid foundation for investors. However, technical indicators suggest cautious optimism due to potential bearish momentum, and valuation concerns persist due to the negative P/E ratio. The absence of recent earnings call insights and corporate events limits additional context.

Chesnara (CSN) vs. iShares MSCI United Kingdom ETF (EWC)

Chesnara Business Overview & Revenue Model

Company DescriptionChesnara plc, together with its subsidiaries, engages in the life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through CA, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products. It distributes its products principally through independent financial advisers. Chesnara plc was incorporated in 2003 and is headquartered in Preston, the United Kingdom.
How the Company Makes MoneyChesnara generates revenue primarily through the management and administration of life insurance and pension policies. The company earns money through premiums collected from policyholders, investment income from the funds it manages, and fees charged for the administration of these policies. In addition, Chesnara benefits from a stable income stream from its in-force policies, which provide ongoing premium payments over time. The company also engages in acquisitions of other insurance businesses, thereby expanding its customer base and increasing its revenue potential. Partnerships with financial advisors and other intermediaries help Chesnara to distribute its products effectively, contributing to its earnings.

Chesnara Financial Statement Overview

Summary
Chesnara demonstrates a solid recovery in revenue and cash flow, indicating improving business operations. While profitability and equity management present challenges, the company shows resilience in managing cash flows and leverage effectively, reflecting a positive trajectory overall.
Income Statement
75
Positive
Chesnara shows a strong recovery in total revenue, growing from a negative revenue of -£1,074 million in 2022 to £1,667 million in 2024, indicating significant improvement. Gross profit margins have remained robust at 100% due to total revenue equaling gross profit. The net profit margin has been low, with a notable dip in 2023 but recovering slightly in 2024. EBIT and EBITDA margins reflect an improving trend, especially a substantial rise in EBIT margin in 2024, indicating improving core operations.
Balance Sheet
65
Positive
The debt-to-equity ratio has remained relatively stable, suggesting consistent leverage management. However, a decrease in stockholders' equity from 2023 to 2024 suggests potential strain on equity. The return on equity (ROE) has been low, reflecting challenges in generating profits relative to equity. Despite these challenges, the equity ratio indicates a moderate level of assets financed by equity, showing fair asset stability.
Cash Flow
70
Positive
Chesnara exhibits a positive turnaround in free cash flow from negative figures in previous years to a positive £37.8 million in 2024, reflecting improved cash generation capabilities. The operating cash flow to net income ratio indicates strong cash flow coverage over net income, enhancing financial flexibility. However, fluctuations in cash flows over the years indicate potential volatility in cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue858.10M1.67B1.03B-720.40M1.50B634.43M
Gross Profit353.00M1.67B1.03B-1.29B1.49B634.43M
EBITDA13.80M49.70M31.40M-48.40M42.19M52.04M
Net Income-7.90M3.90M18.70M-33.70M27.29M21.19M
Balance Sheet
Total Assets13.51B12.76B12.13B11.14B9.42B8.86B
Cash, Cash Equivalents and Short-Term Investments0.00138.00M146.00M204.60M70.09M105.35M
Total Debt203.80M206.20M209.30M213.23M49.46M71.44M
Total Liabilities13.22B12.44B11.77B10.81B8.96B8.37B
Stockholders Equity293.30M314.40M359.90M333.12M458.17M487.07M
Cash Flow
Free Cash Flow44.70M37.80M-35.70M-80.43M20.69M49.34M
Operating Cash Flow45.90M38.60M-34.90M-76.92M24.32M50.20M
Investing Cash Flow4.60M5.00M29.50M52.05M-3.64M1.88M
Financing Cash Flow-33.90M-49.70M-49.80M121.30M-52.25M-61.34M

Chesnara Technical Analysis

Technical Analysis Sentiment
Positive
Last Price280.00
Price Trends
50DMA
272.79
Positive
100DMA
267.21
Positive
200DMA
244.34
Positive
Market Momentum
MACD
1.80
Negative
RSI
59.36
Neutral
STOCH
69.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CSN, the sentiment is Positive. The current price of 280 is above the 20-day moving average (MA) of 274.25, above the 50-day MA of 272.79, and above the 200-day MA of 244.34, indicating a bullish trend. The MACD of 1.80 indicates Negative momentum. The RSI at 59.36 is Neutral, neither overbought nor oversold. The STOCH value of 69.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CSN.

Chesnara Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
£27.21B10.7220.51%1.67%37.94%291.37%
68
Neutral
$623.57M-6.26-8.73%-15.79%-212.00%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
64
Neutral
£378.95M-9.95-76.14%-35.05%74.73%
62
Neutral
£640.35M-61.12-2.53%8.46%-48.03%-289.17%
58
Neutral
£6.73B-10.62-49.24%8.00%-34.62%-19.20%
51
Neutral
£62.61M34.709.65%9.78%-52.34%-65.35%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CSN
Chesnara
280.00
73.87
35.84%
GB:CBG
Close Brothers Group
423.80
204.40
93.16%
GB:PHNX
Phoenix Group Holdings
683.50
235.34
52.51%
GB:PRU
Prudential
1,079.50
421.63
64.09%
GB:SAGA
Saga plc
263.50
153.50
139.55%
GB:HSD
Hansard Global
45.50
2.73
6.38%

Chesnara Corporate Events

Business Operations and StrategyDividends
Chesnara Executives Increase Shareholdings Through Dividend Reinvestment
Positive
Oct 27, 2025

Chesnara plc has announced that its Group CEO, Steve Murray, and Group CFO, Tom Howard, have acquired additional ordinary shares in the company through a dividend reinvestment plan. This acquisition reflects confidence in the company’s ongoing strategy and financial health, as Chesnara continues to focus on efficient policy management and expansion through new business and acquisitions.

The most recent analyst rating on (GB:CSN) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.

Regulatory Filings and Compliance
Chesnara PLC Announces Total Voting Rights Update
Neutral
Oct 6, 2025

Chesnara PLC announced that its issued share capital consists of 230,758,230 ordinary shares, each carrying one voting right, which shareholders can use to determine their interest in the company. This announcement aligns with Chesnara’s commitment to transparency and may impact stakeholders by clarifying their voting rights and interests in the company.

The most recent analyst rating on (GB:CSN) stock is a Hold with a £287.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.

Business Operations and StrategyDelistings and Listing ChangesDividendsFinancial DisclosuresM&A Transactions
Chesnara Achieves Strong Interim Results and Strategic Milestones
Positive
Aug 28, 2025

Chesnara reported strong financial performance in its 2025 interim results, with a 26% increase in cash generation to £37m and a 3% rise in the interim dividend. The company announced a transformational acquisition of HSBC Life (UK), expected to significantly boost cash generation and support long-term growth. Chesnara’s strategic progress includes a successful rights issue and admission to the FTSE 250 Index, positioning the company for further expansion and shareholder value enhancement.

The most recent analyst rating on (GB:CSN) stock is a Buy with a £290.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Chesnara to Announce Interim Results for H1 2025
Neutral
Aug 14, 2025

Chesnara plc is set to announce its interim results for the first half of 2025 on August 28, with a presentation for analysts and investors scheduled for the same day. This announcement is part of Chesnara’s ongoing strategy to maintain transparency and engagement with stakeholders, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.

M&A TransactionsPrivate Placements and Financing
Chesnara PLC Successfully Prices £150 Million Convertible Notes
Positive
Jul 30, 2025

Chesnara PLC announced the successful pricing of £150 million Fixed Rate Reset Perpetual Restricted Tier 1 Contingent Convertible Notes, with proceeds intended for general corporate purposes, including investments and acquisitions. The issuance supports Chesnara’s financial flexibility for future acquisitions, following its recent £140 million Rights Issue for the HSBC Life (UK) transaction, and reflects a positive outlook for mergers and acquisitions.

The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 30, 2025